HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey M Halperin Selected Research

Catecholamines

9/2013Protection from genetic diathesis in attention-deficit/hyperactivity disorder: possible complementary roles of exercise.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey M Halperin Research Topics

Disease

26Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2020 - 05/2002
2Antisocial Personality Disorder (Antisocial Personality)
12/2018 - 07/2006
2Mental Disorders (Mental Disorder)
07/2012 - 08/2009
1Conduct Disorder (Conduct Disorders)
12/2018
1Psychotic Disorders (Schizoaffective Disorder)
01/2017
1DiGeorge Syndrome (Syndrome, DiGeorge)
01/2017
1Autism Spectrum Disorder
01/2017
1Oppositional Defiant Disorder
01/2015
1Substance-Related Disorders (Drug Abuse)
02/2012
1Heroin Dependence (Heroin Abuse)
05/2011

Drug/Important Bio-Agent (IBA)

3Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
07/2017 - 09/2012
3Methylphenidate (Ritalin)FDA LinkGeneric
07/2017 - 09/2012
32- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2015 - 09/2004
2Biomarkers (Surrogate Marker)IBA
01/2020 - 07/2017
2Guanfacine (Tenex)FDA LinkGeneric
03/2015 - 01/2003
2Adrenergic Receptors (Adrenergic Receptor)IBA
03/2013 - 08/2009
2Serotonin (5 Hydroxytryptamine)IBA
07/2006 - 05/2002
1Hydrocortisone (Cortisol)FDA LinkGeneric
12/2018
14-aminospiroperidolIBA
12/2018
1Dopamine Agents (Dopaminergic Agents)IBA
07/2017
1Genetic Markers (Genetic Marker)IBA
01/2017
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
03/2015
1Pemetrexed (MTA)FDA Link
01/2015
1Dopamine (Intropin)FDA LinkGeneric
07/2014
1Dopamine Receptors (Dopamine Receptor)IBA
07/2014
1TeaIBA
05/2014
1Dihydrotachysterol (AT 10)IBA
10/2013
1CatecholaminesIBA
09/2013
1Brain-Derived Neurotrophic Factor (BDNF)IBA
09/2013
1Therapeutic UsesIBA
09/2012
1PlasticsIBA
07/2012
1Biological ProductsIBA
07/2012
1Pharmaceutical PreparationsIBA
02/2012
1Heroin (Diamorphine)IBA
05/2011
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
11/2010
13' Untranslated Regions (3' UTR)IBA
11/2010
14,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA
03/2009
1cytidylyl-(3'-5')-cytidine (CpC)IBA
07/2008
1FenfluramineIBA
05/2007
1Antipsychotic Agents (Antipsychotics)IBA
05/2006
1Valproic Acid (Depakote)FDA LinkGeneric
05/2006
1LithiumIBA
05/2006
1alpha-2 Adrenergic ReceptorsIBA
01/2003
1Growth Hormone (Somatotropin)IBA
01/2003
1ProlactinIBA
05/2002

Therapy/Procedure

1Combined Modality Therapy
01/2015
1Cognitive Training
10/2012
1Secondary Prevention
07/2012
1Occupational Therapy (Therapy, Occupational)
07/2009
1Language Therapy (Language Training)
07/2009
1Physical Therapy Modalities (Physical Therapy Technique)
07/2009
1Oral Administration
01/2003